Brief: EMA Says CHMP Adopted Negative Opinion Recommending Refusal Of Marketing Authorisation For Nouryant
23/07/2021 12:03
July 23 (Reuters) -
* EMA SAYS CHMP ADOPTED A NEGATIVE OPINION RECOMMENDING THE REFUSAL OF A
MARKETING
AUTHORISATION FOR NOURYANT
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia